Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe A Girard

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Medecine Sciences : M/S|November 5, 2020
[Melanoma therapeutic escape: the biomechanical track]Margaux Lecacheur, Christophe A Girard, Marcel Deckert, et al.
Medecine Sciences : M/S|June 19, 2014
[New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy]Christophe A Girard, Barbara Seitz-Polski, Guillaume Dolla, et al.
Nature Clinical Practice. Neurology|November 6, 2007
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11Wojciech Mlynarski, Andrei I Tarasov, Agnieszka Gach, et al.
Cell Reports|October 2, 2025
USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilizationPierric Biber, Alexandrine Carminati, Walaa Mohager, et al.
Free Radical Biology & Medicine|September 3, 2013
PLA2R1 kills cancer cells by inducing mitochondrial stressArnaud Augert, David Vindrieux, Christophe A Girard, et al.
Oncogenesis|June 13, 2026
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathwayMargaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati, et al.
Cancer Research|May 3, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular CellsChristopher Rovera, Ilona Berestjuk, Margaux Lecacheur, et al.
EMBO Molecular Medicine|December 27, 2021
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanomaIlona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2015
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous NephropathyBarbara Seitz-Polski, Guillaume Dolla, Christine Payré, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 26, 2013
Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null miceHafid Ait-Oufella, Olivier Herbin, Charlotte Lahoute, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Medecine Sciences : M/S|November 5, 2020
[Melanoma therapeutic escape: the biomechanical track]Margaux Lecacheur, Christophe A Girard, Marcel Deckert, et al.
Medecine Sciences : M/S|June 19, 2014
[New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy]Christophe A Girard, Barbara Seitz-Polski, Guillaume Dolla, et al.
Nature Clinical Practice. Neurology|November 6, 2007
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11Wojciech Mlynarski, Andrei I Tarasov, Agnieszka Gach, et al.
Cell Reports|October 2, 2025
USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilizationPierric Biber, Alexandrine Carminati, Walaa Mohager, et al.
Free Radical Biology & Medicine|September 3, 2013
PLA2R1 kills cancer cells by inducing mitochondrial stressArnaud Augert, David Vindrieux, Christophe A Girard, et al.
Oncogenesis|June 13, 2026
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathwayMargaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati, et al.
Cancer Research|May 3, 2022
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular CellsChristopher Rovera, Ilona Berestjuk, Margaux Lecacheur, et al.
EMBO Molecular Medicine|December 27, 2021
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanomaIlona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2015
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous NephropathyBarbara Seitz-Polski, Guillaume Dolla, Christine Payré, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 26, 2013
Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null miceHafid Ait-Oufella, Olivier Herbin, Charlotte Lahoute, et al.
Pageof 2